The Interleukin-22/STAT3 Pathway Potentiates Expression of Inducible Nitric-oxide Synthase in Human Colon Carcinoma Cells
Open Access
- 1 June 2007
- journal article
- research article
- Published by Elsevier
- Vol. 282 (22), 16006-16015
- https://doi.org/10.1074/jbc.m611040200
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Interleukin-22: A novel T- and NK-cell derived cytokine that regulates the biology of tissue cellsCytokine & Growth Factor Reviews, 2006
- Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptidesThe Journal of Experimental Medicine, 2006
- Interleukin-22, a Member of the IL-10 Subfamily, Induces Inflammatory Responses in Colonic Subepithelial MyofibroblastsGastroenterology, 2005
- Expression of interleukin‐22 in rheumatoid arthritis: Potential role as a proinflammatory cytokineArthritis & Rheumatism, 2005
- IL-22 Increases the Innate Immunity of TissuesImmunity, 2004
- The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chainJournal of Leukocyte Biology, 2004
- IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissuesInternational Immunopharmacology, 2004
- Interleukin-22 (IL-22) Activates the JAK/STAT, ERK, JNK, and p38 MAP Kinase Pathways in a Rat Hepatoma Cell LineJournal of Biological Chemistry, 2002
- Cutting Edge: Immune Cells as Sources and Targets of the IL-10 Family Members?The Journal of Immunology, 2002
- Interleukin (IL)-22, a Novel Human Cytokine That Signals through the Interferon Receptor-related Proteins CRF2–4 and IL-22RJournal of Biological Chemistry, 2000